Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-6: Switching from Cangrelor to Prasugrel in ACS Patients
NCT04668144Phase 4Completed
- Sponsor
- University of Florida
- Start
- Feb 2021
- Primary completion
- Feb 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor, prasugrel in acute coronary syndrome (ACS), sponsored by University of Florida. Started Feb 2021; status: completed.
02
Drugs
cangrelorprasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04668144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668144.